From Your Health Journal…..”A great article today from Health via HealthDay about the FDA approving new drugs for type 2 diabetes. Type 2 diabetes is on the rise in adults and young children. It is also known as adult onset or non-insulin dependent diabetes. But, these names are not used as much anymore, especially since so many children are getting this disease. The article states that all three drugs contain a new active ingredient, alogliptin to help control blood sugar levels. Type 2 diabetes is the most common form of diabetes. Millions of US citizens have been diagnosed with type 2 diabetes, and many more are unaware they are at high risk. Some groups have a higher risk for developing type 2 diabetes than others. Type 2 diabetes is more common in African Americans, Latinos, Native Americans, and Asian Americans, Native Hawaiians and other Pacific Islanders, as well as the aged population. Please visit the Health web site (link provided below) to read the complete article. They have some great articles, and I always like to promote their site.”

From the article…..

The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.

All three drugs contain a new active ingredient, alogliptin, either alone or in combination with other, previously approved medications. The newly approved drugs include Nesina (alogliptin), Kazano (alogliptin plus metformin) and Oseni (alogliptin plus pioglitazone), the FDA said in a news release.

“Controlling blood sugar levels is very important in the overall treatment and care of diabetes,” Dr. Mary Parks, director of the Division of Metabolism and Endocrinology Products in the FDA’s Center for Drug Evaluation and Research, said in the statement. “Alogliptin helps stimulate the release of insulin after a meal, which leads to better blood sugar control.”

More than 24 million people in the United States are currently affected by type 2 diabetes, which is closely linked with obesity. In the type 2 form of the disease, people gradually develop resistance to insulin or fail to produce enough of the hormone, resulting in rising blood sugar levels. That can lead to other health problems, such as heart disease, vision problems and neural or kidney dysfunction.

The FDA urges that the new medications be used in combination with a healthy diet and exercise to help bring diabetes under control. All of the drugs underwent study either as stand-alone products or used alongside standard diabetes medications such as sulfonyureas or insulin.

To read the complete article…..Click here